| 1 |
32643833 | Radiolabelled CCK2 R Antagonists Containing PEG Linkers: Design, Synthesis and Evaluation. | 2021 Jan 8 |
1 |
| 2 |
30530828 | DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use. | 2019 Jul |
1 |
| 3 |
26844849 | Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor Phosphoramidon. | 2016 Feb |
1 |
| 4 |
21439259 | Preclinical evaluation of 68Ga-DOTA-minigastrin for the detection of cholecystokinin-2/gastrin receptor-positive tumors. | 2011 Apr |
2 |
| 5 |
21461732 | Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides. | 2011 Aug |
2 |
| 6 |
21523391 | Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607. | 2011 Aug |
1 |
| 7 |
20641905 | 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid- d-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | 2004 |
1 |
| 8 |
22091478 | 68Ga-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-d-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | 2004 |
1 |
| 9 |
22787691 | 111In/68Ga-Labeled DOTA-conjugated cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Met-Asp-Phe-NH2 (cyclo-MG1), a minigastrin analog | 2004 |
1 |
| 10 |
22855967 | 111In/68Ga-Labeled DOTA conjugated cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Nle-Asp-Phe-NH2 (cyclo-MG2), a minigastrin analog | 2004 |
1 |
| 11 |
23390663 | 68Ga-Labeled DOTA-conjugated sCCK8[Phe2(p-CH2SO3H),Nle3,6], a sulfated cholecystokinin 8 (sCCK8) peptide derivative | 2004 |
1 |
| 12 |
23390667 | 111In-Labeled DOTA-conjugated sCCK8[Phe2(p-CH2SO3H),Nle3,6], a sulfated cholecystokinin 8 (sCCK8) peptide derivative | 2004 |
1 |
| 13 |
9575243 | Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo. | 1998 May |
1 |